HERON THERAPEUTICS, INC. /DE/ - COM (HRTX)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
119 M
Holdings value Q1 2024
$330 M
Value change Q1 2024
+$20.5 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
152
Number of buys Q1 2024
67
Number of sells Q1 2024
-61
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
427746102
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 119 M $330 M +$20.5 M $2.77 152
2023 Q4 112 M $190 M +$1.03 M $1.70 146
2023 Q3 118 M $122 M +$20 M $1.03 136
2023 Q2 98.5 M $114 M -$11.7 M $1.16 139
2023 Q1 101 M $152 M -$16.2 M $1.51 148
2022 Q4 116 M $289 M -$30.9 M $2.50 172
2022 Q3 118 M $498 M +$44.2 M $4.22 170
2022 Q2 112 M $313 M +$4.2 M $2.79 155
2022 Q1 108 M $619 M -$95.4 M $5.72 175
2021 Q4 117 M $1.07 B +$79.7 M $9.13 187
2021 Q3 107 M $1.15 B +$45.4 M $10.69 190
2021 Q2 103 M $1.6 B +$204 M $15.52 185
2021 Q1 90.5 M $1.47 B -$13.8 M $16.21 186
2020 Q4 89.6 M $1.9 B +$27.9 M $21.16 175
2020 Q3 90.8 M $1.35 B +$33 M $14.82 167
2020 Q2 85.6 M $1.29 B -$48.8 M $14.71 177
2020 Q1 91.8 M $1.08 B -$128 M $11.74 178
2019 Q4 98.4 M $2.31 B +$190 M $23.50 188
2019 Q3 85.8 M $1.59 B -$40 M $18.50 166
2019 Q2 93.8 M $1.74 B +$14.3 M $18.59 164
2019 Q1 86.5 M $2.11 B +$26.5 M $24.44 185
2018 Q4 85.3 M $2.21 B +$96.8 M $25.94 164
2018 Q3 81.5 M $2.58 B +$144 M $31.65 183
2018 Q2 76.4 M $2.95 B +$199 M $38.85 191
2018 Q1 72.5 M $2 B +$345 M $27.60 150
2017 Q4 60.5 M $1.09 B +$99.7 M $18.10 121
2017 Q3 63.3 M $1.02 B -$89.8 M $16.15 100
2017 Q2 60.7 M $841 M +$47.5 M $13.85 99
2017 Q1 62.4 M $936 M +$300 M $15.00 94
2016 Q4 52.4 M $686 M +$4.71 M $13.10 89
2016 Q3 44.9 M $773 M +$71.9 M $17.23 87
2016 Q2 47 M $848 M +$17.2 M $18.05 88
2016 Q1 39.8 M $756 M -$8.62 M $18.99 98
2015 Q4 45.2 M $1.21 B +$41.6 M $26.70 100
2015 Q3 43.7 M $1.06 B +$172 M $24.40 104
2015 Q2 35.8 M $1.12 B +$319 M $31.16 86
2015 Q1 26.1 M $380 M +$30.8 M $14.55 63
2014 Q4 24.6 M $247 M +$2.54 M $10.06 62
2014 Q3 24.2 M $202 M -$7.8 M $8.33 54
2014 Q2 26.5 M $326 M +$63.3 M $12.32 65
2014 Q1 16.4 M $228 M +$222 M $13.91 38